Organized by Captive Review, the UK Captive Services Awards, recognize excellence in the delivery and management of captive insurance. Being named the Captive Healthcare Specialist of the Year is an honor, and reflects MAXIS GBNs commitment to providing tailored solutions and world-class services that meet the business needs of our multinational customers, said Jim Peiffer, managing director, MAXIS GBN, and senior vice president, MetLife. By understanding and aligning our customers global and local priorities, we are able to help our customers manage their worldwide employee benefits programs through flexible and innovative solutions, including our industry-leading health and wellness programs. The UK Captive Services Awards recognize companies that have outperformed their peer group over the course of the past year. The awards are judged on the criteria of 1) company growth: client numbers, premium/assets under management, internal hires, geographic expansion; 2) client satisfaction; 3) genuine product innovation; and 4) adaptability: in the face of client demands and new regulation, etc. The judging panel consists of representatives from Captive Review, industry experts and corporate risk managers. “The Captive Healthcare Specialist Award is a prestigious one, as medical captives represent a thriving, fast growing sector of the captive industry. MAXIS GBN is not only a leader in the medical captive space, but goes the extra mile when it comes to data analysis and implementation of risk management initiatives that ultimately benefit the health of the insureds,” said Antony Ireland, acting editor, Captive Review. The award recognized MAXIS GBN for its leading healthcare management and wellness solutions. MAXIS GBN offers through its members, medical insurance and health and wellness capabilities in 85 markets with over four million insureds. With its customer-centric focus, MAXIS GBN delivers customer-specific analysis of medical claims, research insights on wellness, client discussion forums, and perspectives on local health and wellness solutions. About MAXIS GBN MAXIS GBN was founded in 1998 by AXA and MetLife, two leading global insurers. MAXIS GBN includes locally licensed member insurance companies in over 110 countries, is trusted by over 750 multinational employers and covers 1.5 million employees worldwide. For more information, please visit http://www.maxis-gbn.com .
Palliative specialists support UK care pathway
A similarly high number of doctors indicated that they would want the pathway themselves if they were terminally ill, show the results. “The Liverpool care pathway is the most widely used integrated care pathway for end of life care, but it has recently been criticised after accounts in the media of patients having food and fluids withdrawn and hospitals being offered financial incentives for using the pathway,” writes Krishna Chinthapalli (British Medical Journal [BMJ], London, UK) in the BMJ. The journal emailed 3021 hospital doctors to gauge their views of the care pathway, which engages a multidisciplinary team to assess whether a patient is indeed dying, and to consider and agree on palliative care options, including whether nonessential treatments and medications should be discontinued. Of the 647 respondents, 185 were palliative medicine consultants, 168 were doctors in training or career grade posts in palliative medicine, and 210 were doctors of other specialties. A total of 87% reported having used the LCP in clinical practice. However, 57% of respondents felt that recent negative press in the UK media has led to the care pathway being used less. Almost three-quarters (74%) of palliative medicine specialists felt this way. Indeed, 60% of doctors who believed there was less use of the pathway as a result of a negative perception in the UK media said that relatives of dying patients had asked them not to use it, and that 80% of staff were apprehensive about it. One palliative medicine specialist said: “Negative press regarding the LCP has caused additional distress for relatives at an already distressing time when their loved one is dying. This has caused a dilemma in judging if discussing the LCP will cause more distress than the benefit of being on the LCP.” Notably, 90% of doctors said that they would want the pathway themselves during a terminal illness, although the questionnaire did not make it clear whether that meant dying from a terminal illness.